News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
664,113 Results
Type
Article (47752)
Company Profile (354)
Press Release (615994)
Multimedia
Podcasts (146)
Webinars (24)
Section
Business (178272)
Career Advice (2610)
Deals (32443)
Drug Delivery (144)
Drug Development (80921)
Employer Resources (153)
FDA (15589)
Job Trends (13654)
News (313306)
Policy (30670)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2795)
Academic (1)
Accelerated approval (55)
ADA (49)
Adcomms (37)
Allergies (198)
Alliances (44837)
ALS (233)
Alzheimer's disease (1932)
Antibody-drug conjugate (ADC) (547)
Approvals (15982)
Artificial intelligence (757)
ASCO (345)
Autoimmune disease (350)
Automation (55)
Bankruptcy (338)
Best Places to Work (11023)
BIOSECURE Act (18)
Biosimilars (226)
Biotechnology (260)
Bladder cancer (206)
Brain cancer (80)
Breast cancer (812)
Cancer (6414)
Cardiovascular disease (533)
Career advice (2231)
Career pathing (48)
CAR-T (376)
CDC (62)
Celiac Disease (2)
Cell therapy (1017)
Cervical cancer (50)
Clinical research (70631)
Collaboration (2227)
Commercialization (1)
Company closure (6)
Compensation (1121)
Complete response letters (102)
COVID-19 (2806)
CRISPR (124)
C-suite (1282)
Cystic fibrosis (161)
Data (8658)
Decentralized trials (3)
Denatured (37)
Depression (189)
Dermatology (94)
Diabetes (671)
Diagnostics (6695)
Digital health (56)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (377)
Drug pricing (215)
Drug shortages (36)
Duchenne muscular dystrophy (316)
Earnings (72745)
Editorial (75)
Employer branding (21)
Employer resources (143)
Events (102340)
Executive appointments (1172)
FDA (19524)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1840)
Gene editing (264)
Generative AI (66)
Gene therapy (812)
GLP-1 (1177)
Government (4864)
Grass and pollen (8)
Guidances (415)
Healthcare (18236)
Hematology (181)
HIV (92)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (341)
Immuno-oncology (111)
Indications (210)
Infectious disease (3184)
Inflammatory bowel disease (240)
Inflation Reduction Act (16)
Influenza (141)
Intellectual property (317)
Interviews (545)
IPO (15152)
IRA (56)
Job creations (2949)
Job search strategy (1791)
JPM (69)
Kidney cancer (22)
Labor market (89)
Layoffs (593)
Leadership (51)
Legal (6784)
Liver cancer (109)
Longevity (31)
Lung cancer (862)
Lymphoma (469)
Machine learning (63)
Management (53)
Manufacturing (1102)
Marketing (1)
MASH (227)
Medical affairs (1)
Medical device (12449)
Medtech (12593)
Mergers & acquisitions (18558)
Metabolic disorders (1727)
mRNA (247)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (491)
Neuropsychiatric disorders (125)
Neuroscience (3635)
Neurotech (1)
NextGen: Class of 2026 (6251)
Non-profit (4316)
Now hiring (77)
Obesity (804)
Opinion (351)
Ovarian cancer (241)
Pain (273)
Pancreatic cancer (351)
Parkinson's disease (410)
Partnered (35)
Patents (633)
Patient recruitment (755)
Peanut (69)
People (58618)
Pharmaceutical (54)
Pharmacy benefit managers (29)
Phase 1 (22126)
Phase 2 (31155)
Phase 3 (23206)
Pipeline (9674)
Policy (353)
Postmarket research (2491)
Preclinical (9423)
Press Release (64)
Prostate cancer (341)
Psychedelics (70)
Radiopharmaceuticals (358)
Rare diseases (1233)
Real estate (4845)
Recruiting (67)
Regulatory (24872)
Reports (35)
Research institute (2444)
Resumes & cover letters (385)
Rett syndrome (44)
RNA editing (30)
RSV (89)
Schizophrenia (194)
Series A (317)
Series B (237)
Service/supplier (4)
Sickle cell disease (128)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (46)
Startups (3378)
State (2)
Stomach cancer (20)
Supply chain (125)
Tariffs (84)
The Weekly (107)
Vaccines (1162)
Venture capital (129)
Weight loss (541)
Women's health (118)
Worklife (21)
Date
Today (90)
Last 7 days (438)
Last 30 days (2543)
Last 365 days (29995)
2026 (15387)
2025 (29780)
2024 (34495)
2023 (38545)
2022 (49557)
2021 (53518)
2020 (51784)
2019 (44218)
2018 (33364)
2017 (31012)
2016 (29714)
2015 (34762)
2014 (27001)
2013 (22092)
2012 (23421)
2011 (24303)
2010 (21997)
Location
Africa (814)
Alabama (95)
Alaska (4)
Arizona (302)
Arkansas (14)
Asia (41307)
Australia (7836)
California (13108)
Canada (3835)
China (1532)
Colorado (560)
Connecticut (553)
Delaware (429)
Europe (91304)
Florida (2008)
Georgia (415)
Hawaii (3)
Idaho (62)
Illinois (1074)
India (100)
Indiana (605)
Iowa (20)
Japan (589)
Kansas (129)
Kentucky (47)
Louisiana (57)
Maine (67)
Maryland (1616)
Massachusetts (9695)
Michigan (349)
Minnesota (703)
Mississippi (6)
Missouri (148)
Montana (35)
Nebraska (26)
Nevada (142)
New Hampshire (88)
New Jersey (3594)
New Mexico (30)
New York (3449)
North Carolina (1706)
North Dakota (9)
Northern California (6497)
Ohio (383)
Oklahoma (20)
Oregon (41)
Pennsylvania (2594)
Puerto Rico (29)
Rhode Island (47)
South America (1110)
South Carolina (84)
South Dakota (2)
Southern California (5306)
Tennessee (203)
Texas (2157)
United States (46902)
Utah (404)
Vermont (2)
Virginia (332)
Washington D.C. (71)
Washington State (1079)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
664,113 Results for "prescient therapeutics formerly known as virax holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
May 26, 2026
·
6 min read
Press Releases
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
March 31, 2026
·
5 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
June 5, 2026
·
4 min read
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
November 4, 2025
·
5 min read
Press Releases
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
August 27, 2025
·
5 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
May 7, 2026
·
4 min read
Press Releases
Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits
May 29, 2026
·
7 min read
1 of 66,412
Next
